hormone replacement therapy + etidronate

A combination therapy approach using hormone replacement therapy (HRT) and etidronate for treating bone loss in postmenopausal women. HRT replaces hormones that decline during menopause, while etidronate is a bisphosphonate that inhibits bone resorption by interfering with osteoclast activity. This combination has shown an additive effect on bone mineral density in the hip and vertebrae, particularly beneficial for women who continue to lose bone density despite conventional HRT alone.

Other names

combined therapy with estrogen and etidronateintermittent cyclical etidronate and hormone replacement therapyICT-etidronate combined with HRT